Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin

In this study, we investigated whether the curcuminoids, CLEFMA and EF24, improved cisplatin efficacy and reduced cisplatin ototoxicity. We used the lung cancer cell line, A549, to determine the effects of the curcuminoids and cisplatin on cell viability and several apoptotic signaling mechanisms. C...

Full description

Bibliographic Details
Main Authors: Jerry D. Monroe, Denis Hodzic, Matthew H. Millay, Blaine G. Patty, Michael E. Smith
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/24/21/3889
_version_ 1818923372683198464
author Jerry D. Monroe
Denis Hodzic
Matthew H. Millay
Blaine G. Patty
Michael E. Smith
author_facet Jerry D. Monroe
Denis Hodzic
Matthew H. Millay
Blaine G. Patty
Michael E. Smith
author_sort Jerry D. Monroe
collection DOAJ
description In this study, we investigated whether the curcuminoids, CLEFMA and EF24, improved cisplatin efficacy and reduced cisplatin ototoxicity. We used the lung cancer cell line, A549, to determine the effects of the curcuminoids and cisplatin on cell viability and several apoptotic signaling mechanisms. Cellular viability was measured using the MTT assay. A scratch assay was used to measure cell migration and fluorescent spectrophotometry to measure reactive oxygen species (ROS) production. Western blots and luminescence assays were used to measure the expression and activity of apoptosis-inducing factor (AIF), caspases-3/7, -8, -9, and -12, c-Jun N-terminal kinases (JNK), mitogen-activated protein kinase (MAPK), and proto-oncogene tyrosine-protein kinase (Src). A zebrafish model was used to evaluate auditory effects. Cisplatin, the curcuminoids, and their combinations had similar effects on cell viability (IC<sub>50</sub> values: 2&#8722;16 &#956;M) and AIF, caspase-12, JNK, MAPK, and Src expression, while caspase-3/7, -8, and -9 activity was unchanged or decreased. Cisplatin increased ROS yield (1.2-fold), and curcuminoid and combination treatments reduced ROS (0.75&#8722;0.85-fold). Combination treatments reduced A549 migration (0.51&#8722;0.53-fold). Both curcuminoids reduced auditory threshold shifts induced by cisplatin. In summary, cisplatin and the curcuminoids might cause cell death through AIF and caspase-12. The curcuminoids may potentiate cisplatin&#8217;s effect against A549 migration, but may counteract cisplatin&#8217;s effect to increase ROS production. The curcuminoids might also prevent cisplatin ototoxicity.
first_indexed 2024-12-20T02:08:24Z
format Article
id doaj.art-ef35818d7762451598aaab723c8e3cfe
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-20T02:08:24Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-ef35818d7762451598aaab723c8e3cfe2022-12-21T19:57:07ZengMDPI AGMolecules1420-30492019-10-012421388910.3390/molecules24213889molecules24213889Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with CisplatinJerry D. Monroe0Denis Hodzic1Matthew H. Millay2Blaine G. Patty3Michael E. Smith4Department of Biology, Western Kentucky University, 1906 College Heights Boulevard, #11080, Bowling Green, KY 42101-1080, USADepartment of Biology, Western Kentucky University, 1906 College Heights Boulevard, #11080, Bowling Green, KY 42101-1080, USADepartment of Biology, Western Kentucky University, 1906 College Heights Boulevard, #11080, Bowling Green, KY 42101-1080, USADepartment of Biology, Western Kentucky University, 1906 College Heights Boulevard, #11080, Bowling Green, KY 42101-1080, USADepartment of Biology, Western Kentucky University, 1906 College Heights Boulevard, #11080, Bowling Green, KY 42101-1080, USAIn this study, we investigated whether the curcuminoids, CLEFMA and EF24, improved cisplatin efficacy and reduced cisplatin ototoxicity. We used the lung cancer cell line, A549, to determine the effects of the curcuminoids and cisplatin on cell viability and several apoptotic signaling mechanisms. Cellular viability was measured using the MTT assay. A scratch assay was used to measure cell migration and fluorescent spectrophotometry to measure reactive oxygen species (ROS) production. Western blots and luminescence assays were used to measure the expression and activity of apoptosis-inducing factor (AIF), caspases-3/7, -8, -9, and -12, c-Jun N-terminal kinases (JNK), mitogen-activated protein kinase (MAPK), and proto-oncogene tyrosine-protein kinase (Src). A zebrafish model was used to evaluate auditory effects. Cisplatin, the curcuminoids, and their combinations had similar effects on cell viability (IC<sub>50</sub> values: 2&#8722;16 &#956;M) and AIF, caspase-12, JNK, MAPK, and Src expression, while caspase-3/7, -8, and -9 activity was unchanged or decreased. Cisplatin increased ROS yield (1.2-fold), and curcuminoid and combination treatments reduced ROS (0.75&#8722;0.85-fold). Combination treatments reduced A549 migration (0.51&#8722;0.53-fold). Both curcuminoids reduced auditory threshold shifts induced by cisplatin. In summary, cisplatin and the curcuminoids might cause cell death through AIF and caspase-12. The curcuminoids may potentiate cisplatin&#8217;s effect against A549 migration, but may counteract cisplatin&#8217;s effect to increase ROS production. The curcuminoids might also prevent cisplatin ototoxicity.https://www.mdpi.com/1420-3049/24/21/3889cancercurcuminoidcisplatinzebrafishreactive oxygen speciesauditory evoked potentialapoptosiscell migration
spellingShingle Jerry D. Monroe
Denis Hodzic
Matthew H. Millay
Blaine G. Patty
Michael E. Smith
Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
Molecules
cancer
curcuminoid
cisplatin
zebrafish
reactive oxygen species
auditory evoked potential
apoptosis
cell migration
title Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
title_full Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
title_fullStr Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
title_full_unstemmed Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
title_short Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
title_sort anti cancer and ototoxicity characteristics of the curcuminoids clefma and ef24 in combination with cisplatin
topic cancer
curcuminoid
cisplatin
zebrafish
reactive oxygen species
auditory evoked potential
apoptosis
cell migration
url https://www.mdpi.com/1420-3049/24/21/3889
work_keys_str_mv AT jerrydmonroe anticancerandototoxicitycharacteristicsofthecurcuminoidsclefmaandef24incombinationwithcisplatin
AT denishodzic anticancerandototoxicitycharacteristicsofthecurcuminoidsclefmaandef24incombinationwithcisplatin
AT matthewhmillay anticancerandototoxicitycharacteristicsofthecurcuminoidsclefmaandef24incombinationwithcisplatin
AT blainegpatty anticancerandototoxicitycharacteristicsofthecurcuminoidsclefmaandef24incombinationwithcisplatin
AT michaelesmith anticancerandototoxicitycharacteristicsofthecurcuminoidsclefmaandef24incombinationwithcisplatin